Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
Titel:
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
Auteur:
Maurer, Marcus Lumry, William R. Li, H. Henry Aygören-Pürsün, Emel Busse, Paula J. Jacobs, Joshua Nurse, Christina Ahmed, Mariam A. Watt, Maureen Yu, Ming
Verschenen in:
The journal of allergy and clinical immunology. In practice